Predictors of hospital discharge in cancer patients with pericardial effusion undergoing surgical pericardial drainage

2018 ◽  
Vol 119 (1) ◽  
pp. 143-147 ◽  
Author(s):  
Thamara Kazantzis ◽  
Benoit Jacques Bibas ◽  
Alberto Jorge Dela‐Vega ◽  
Pedro Nabuco ◽  
Leticia Leone Lauricella ◽  
...  
2020 ◽  
Vol 41 (Supplement_1) ◽  
Author(s):  
C Ho ◽  
P H Lee ◽  
T C So ◽  
M C S Chiang ◽  
M H Wong ◽  
...  

Abstract On Behalf Cardiac Team, Department of Medicine, Queen Elizabeth Hospital Background Management of significant pericardial effusion in cancer patients is controversial. These patients have poor prognosis, and avoiding unnecessary intervention is important. Close monitoring of symptoms and echocardiogram is often a reasonable option, but inherits risk of cardiac tamponade. Whether pericardial drainage by means of percutaneous pericardiocentesis or surgical pericardiotomy could prevent future deterioration or affect survival is unknown. Purpose To evaluate the benefit of elective pericardial drainage in malignancy associated pericardial effusion without echocardiographic or clinical evidence of tamponade effect. Methods From 1st Jul 2014 to 31st Dec 2017, all patients with new onset malignancy-associated pericardial effusion with size more than 1cm were retrospectively analyzed. Patients with clinical or echocardiographic evidence of cardiac tamponade were excluded. We compared pericardial drainage versus monitoring for short-term (30-day), mid-term (90-day) and long term (1 year) survival without need for drainage. Results 101 patients were retrospectively analyzed. 40 (39.6%) patients underwent drainage. Overall median survival free from drainage was 4 months. There were no significant difference in short-term (30-day), mid-term (90-day) and long term (1-year) survival free from drainage or mortality between treatment and monitoring group. Size of pericardial effusion did not predict mortality or future need of drainage. Chemotherapy was associated with improved 30-day mortality (RR 0.53 CI 0.32-0.87 p = 0.025) but not survival free from drainage or longer term mortality. Conclusion Close monitoring could be a feasible strategy in cancer patients with significant pericardial effusion without tamponade effect. Baseline characteristics Factor Drainage (n = 40) monitoring (n = 61) p-value method of drainage pericardiocentesis alone 17 NA pericardiotomy alone 13 both 10 Male 19 (47.5%) 27 (44.3%) 0.749 mean size (cm) 1.93 2.77 <0.001 mean age 60.9 63.1 0.357 on chemotherapy 27 (67.5%) 38 (62.3%) 0.593 Abstract 224 Figure. Survival free from drainage


2012 ◽  
pp. 66-71
Author(s):  
Quang Thuu Le

Objective: Today, despite many recent improvements in intraoperative management and postoperative care, late pericardial effusions remain an important cause of morbidity after cardiac surgery. Because of widespread use of chronic anticoagulation and increased complexity of operations, the incidence of effusion may be higher. Thus we need to update the information on the symptoms, risk factors, diagnostic methods and treatment of Postoperative pericardial effusion syndrome. Patients and methods: A cross-sectional and prospective study of all patients admitted to hospital because of pericardial effusion after open heart surgery from 1/2010 to 9/2012. Study the clinical characteristics, paraclinicals, evaluate the results of treatment of pericardial effusion after open heart surgery. Results: Symptoms of pericardial effusion are nonspecific. Some patients with pericardial effusion report minimal problems. In the present study, few patients have the classic presentation of tamponade. Echocardiography is the diagnostic accuracy pericardial effusion after open heart surgery. This treatment mainly is pericardial drainage with 100%. Conclusion: Pericardial effusion is a common complication after open-heart surgery, symptoms of pericardial effusion are nonspecific to diagnostic method is echocardiographic surveillance.patients can be treated with internal medicine if has no tamponade and less fliuds. Pericardial drainage is absolute only in patients with pericardial effusion with signs of cardiac tamponade or pericardial many of effusion.


2020 ◽  
Vol 55 (2) ◽  
pp. 86-93
Author(s):  
Alejandro Cruz-Utrilla ◽  
Carlos Ferrera ◽  
Marcos Ferrández-Escarabajal ◽  
Cristina Sánchez-Enrique ◽  
Iván Núñez-Gil ◽  
...  

1998 ◽  
Vol 105 (2) ◽  
pp. 106-109 ◽  
Author(s):  
Jordi Mercé ◽  
Jaume Sagristà-Sauleda ◽  
Gaietà Permanyer-Miralda ◽  
Jordi Soler-Soler

2018 ◽  
Vol 127 ◽  
pp. S735
Author(s):  
M. Arquez-Pianetta ◽  
L. Torres ◽  
C. Ligero ◽  
M. Sousa ◽  
M. Arenas ◽  
...  

2013 ◽  
Vol 87 (3) ◽  
pp. 487-493 ◽  
Author(s):  
Junichi Fukada ◽  
Naoyuki Shigematsu ◽  
Hiroya Takeuchi ◽  
Toshio Ohashi ◽  
Yoshiro Saikawa ◽  
...  

2017 ◽  
Vol 1 (0) ◽  
pp. 19 ◽  
Author(s):  
Kyriacos Mouyis ◽  
Sofia Metaxa ◽  
Constantinos Missouris

Sign in / Sign up

Export Citation Format

Share Document